DONALD LEUNG, MD
Osteopathic Medicine at Jackson St, Denver, CO
License number
Colorado 29944
Category
Medical Practice
Type
Pediatric Allergy/Immunology
License number
Colorado 29944
Category
Osteopathic Medicine
Type
Allergy & Immunology
Address
Address
1400 Jackson St, Denver, CO 80206
Phone
(303) 388-4461
(303) 270-2174 (Fax)
(303) 270-2174 (Fax)
Personal information
See more information about DONALD LEUNG at radaris.comName
Address
Phone
400 S Steele St UNIT 22, Denver, CO 80209
Denver, CO
5267 Geneva St, Englewood, CO 80111
8623 Colonial Dr, Littleton, CO 80124
Professional information
Donald Yap Man Leung, Denver CO
Specialties:
Allergy & Immunology, Diagnostic Laboratory Immunology, Allergy, Pediatrics, Pediatric Allergy & Immunology
Work:
Main Campus
1400 Jackson St, Denver, CO 80206
1400 Jackson St, Denver, CO 80206
Education:
University of Chicago (1977)
Dr. Donald Leung, Denver CO - MD (Doctor of Medicine)
Specialties:
Diagnostic Laboratory & Dermatologic Immunology
Address:
National Jewish Health
1400 Jackson St, Denver 80206
(303) 388-4461 (Phone), (303) 398-1476 (Fax)
1400 Jackson St, Denver 80206
(303) 388-4461 (Phone), (303) 398-1476 (Fax)
Certifications:
Allergy & Immunology, 1983, Diagnostic Laboratory Immunology, 1990, Pediatrics, 1982
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
National Jewish Health
1400 Jackson St, Denver 80206
National Jewish Health
1400 Jackson St, Denver 80206
1400 Jackson St, Denver 80206
National Jewish Health
1400 Jackson St, Denver 80206
Education:
Medical School
University Of Chicago/The Pritzker School Of Medicine
Graduated: 1977
Children's Hospital Boston
Graduated: 1978
Graduated: 1979
University Of Chicago/The Pritzker School Of Medicine
Graduated: 1977
Children's Hospital Boston
Graduated: 1978
Graduated: 1979
Cationic Steroid Antimicrobial Compositions And Methods Of Use
US Patent:
2013003, Feb 7, 2013
Filed:
Jun 29, 2012
Appl. No.:
13/538676
Inventors:
Paul B. Savage - Mapleton UT, US
Donald Y.M. Leung - Denver CO, US
Donald Y.M. Leung - Denver CO, US
International Classification:
A61K 31/575, C12Q 1/70, A61P 31/22, C12N 5/07, A61K 39/42, A61K 49/00
US Classification:
424 92, 514182, 514170, 514171, 4241591, 435375, 435 5
Abstract:
The invention provides methods for decreasing or inhibiting herpesviridae (HV) infection or pathogenesis of a cell in vitro, ex vivo or in vivo, a symptom or pathology associated with a herpesviridae (HV) infection or pathogenesis in vitro, ex vivo or in vivo, or an adverse side effect of herpesviridae (HV) infection or pathogenesis in vitro, ex vivo or in vivo. In one embodiment, a method of the invention includes treating a subject with an invention compound (e.g., cationic steroid antimicrobial or CSA).
Method For Treating A Steroid Resistant Condition Via Administration Of Gamma Interferon
US Patent:
5266312, Nov 30, 1993
Filed:
Jan 7, 1992
Appl. No.:
7/817577
Inventors:
Donald Leung - Denver CO
Stanley Szefler - Denver CO
Stanley Szefler - Denver CO
Assignee:
National Jewis Center for Immunology and Respiratory Medicine - Denver CO
International Classification:
A61K 3700, A61K 3766
US Classification:
424 855
Abstract:
The invention relates to a method for a steroid resistant condition via administration of gamma interferon to a subject, such as a human, afflicted with the condition. The gamma interferon is administered in an amount sufficient to alleviate at least one parameter associated with the steroid resistant condition.
Human Cathelicidin Antimicrobial Peptides
US Patent:
7718618, May 18, 2010
Filed:
Oct 20, 2004
Appl. No.:
10/575552
Inventors:
Richard L. Gallo - San Diego CA, US
Masamoto Murakami - Hokkaido, JP
Donald Y.M. Leung - Denver CO, US
Masamoto Murakami - Hokkaido, JP
Donald Y.M. Leung - Denver CO, US
Assignee:
The Regents of the University of California - Oakland CA
National Jewish Medical and Research Center - Denver CO
National Jewish Medical and Research Center - Denver CO
International Classification:
A61K 38/10, A61K 38/16
US Classification:
514 13, 514 12, 530324, 530325, 530326
Abstract:
Provided are peptide and peptide consensus sequences, which inhibit bacterial growth and/or viral growth and mimic the activity of LL-37, CRAMP, and/or FALL-39. The peptides are useful as antimicrobials, anti-inflammatories and anti-viral agents.
Anti-Viral Activity Of Cathelicidin Peptides
US Patent:
2006029, Dec 28, 2006
Filed:
Mar 5, 2004
Appl. No.:
10/546739
Inventors:
Richard Gallo - San Diego CA, US
Donald Leung - Denver CO, US
James Jones - Decatur GA, US
Donald Leung - Denver CO, US
James Jones - Decatur GA, US
International Classification:
A61K 38/16, C07K 14/005, C12Q 1/70, C12Q 1/68, C07H 21/04, C12P 21/06, C12N 15/86
US Classification:
435005000, 530350000, 435006000, 435456000, 435069100, 435325000, 514012000, 536023500
Abstract:
The disclosure provides methods and compositions useful in the treatment of dermatitis and viral infections. The compositions comprise cationic peptides of the cathelicidin family including LL-37, related homologues, and variants thereof.